High C-reactive protein in Crohn's disease patients predicts nonresponse to infliximab treatment

Abstract

CRP levels at week 14 were associated with SR in patients treated with IFX, independently of baseline CRP serum levels. High inflammatory burden at beginning of IFX treatment was correlated with a worse response.